LAVSX
Price
$16.27
Change
-$0.07 (-0.43%)
Updated
Aug 14 closing price
Net Assets
2.05B
RMFEX
Price
$60.61
Change
-$0.02 (-0.03%)
Updated
Aug 14 closing price
Net Assets
109.95B
Interact to see
Advertisement

LAVSX vs RMFEX

Header iconLAVSX vs RMFEX Comparison
Open Charts LAVSX vs RMFEXBanner chart's image
Lord Abbett Fundamental Equity R4
Price$16.27
Change-$0.07 (-0.43%)
VolumeN/A
Net Assets2.05B
American Funds American Mutual R4
Price$60.61
Change-$0.02 (-0.03%)
VolumeN/A
Net Assets109.95B
LAVSX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAVSX vs. RMFEX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAVSX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 110B vs. LAVSX (2.05B). RMFEX pays higher dividends than LAVSX: RMFEX (1.51) vs LAVSX (0.82). LAVSX was incepted earlier than RMFEX: LAVSX (10 years) vs RMFEX (23 years). LAVSX (0.95) is less costly to investors than RMFEX (0.62). LAVSX is a more actively managed with annual turnover of: 39.00 vs. RMFEX (31.00). LAVSX has a lower initial minimum investment than RMFEX: LAVSX (0) vs RMFEX (250). RMFEX (9.41) and LAVSX (9.11) have marching annual gain over last year. RMFEX return over 5 years is better than : 57.73 vs. LAVSX (53.34).
LAVSXRMFEXLAVSX / RMFEX
Total Expense Ratio0.950.62153%
Annual Report Gross Expense Ratio0.950.62153%
Fund Existence10 years23 years-
Gain YTD9.22511.19782%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.05B110B2%
Annual Yield % from dividends0.821.5154%
Returns for 1 year9.119.4197%
Returns for 3 years29.4524.51120%
Returns for 5 years53.3457.7392%
Returns for 10 years29.4186.1534%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMNWX85.48N/A
N/A
Principal Capital Appreciation A
ABRWX18.32N/A
N/A
DSS AmericaFirstMonthlyRisk-OnRisk-Off I
PGHAX61.90N/A
N/A
Putnam Global Health Care R6
GHAYX43.52N/A
N/A
VanEck Global Resources Fund Y
TEOIX10.03N/A
N/A
Transamerica Emerging Markets Eq I